XT
DNA icon

XTX Topco’s Ginkgo Bioworks DNA Stock Holding History

XTX Topco’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-53,994
Closed -$607K – 2713
2025
Q2 		$607K Buy
+53,994
New +$418K 0.03% 965
2024
Q3 		– Sell
-23,347
Closed -$312K – 2198
2024
Q2 		$312K Buy
+23,347
New +$697K 0.03% 932
2023
Q4 		– Sell
-1,624
Closed -$118K – 1705
2023
Q3 		$118K Buy
+1,624
New +$130K 0.02% 1164
2023
Q1 		– Sell
-4,555
Closed -$308K – 1364
2022
Q4 		$308K Buy
4,555
+2,931
+180% +$270K 0.07% 566
2022
Q3 		$203K Buy
1,624
+1,152
+244% +$137K 0.05% 769
2022
Q2 		$45K Buy
472
+166
+54% +$20.2K 0.02% 751
2022
Q1 		$49K Sell
306
-153
-33% -$29.8K 0.02% 592
2021
Q4 		$153K Buy
+459
New +$218K 0.09% 407

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

XTX Topco's DNA Position: Q3 2025 in Review

XTX Topco sold out of Ginkgo Bioworks (DNA) in Q3 2025, closing a stake of 53,994 shares — an estimated $607K sold.

XTX Topco first reported a position in DNA in Q4 2021 and held it in 8 quarters. The position peaked at $607K in Q2 2025. 174 funds tracked by Wall St. Rank hold DNA as of Q3 2025.

  • XTX Topco reported no remaining Ginkgo Bioworks position as of Q3 2025 after selling out during the quarter.
  • XTX Topco sold 53,994 Ginkgo Bioworks shares in Q3 2025, an estimated $607K.
  • XTX Topco first reported a position in Ginkgo Bioworks in Q4 2021 and held it in 8 quarters.
  • XTX Topco's Ginkgo Bioworks position peaked at $607K in Q2 2025.
  • 174 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2025.

Based on XTX Topco's 13F filing for Q3 2025, filed 14 Nov 2025.